{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:39Z","timestamp":1786995639445,"version":"build-2736575974"},"reference-count":273,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.pharmthera.2020.107684","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:16:28Z","timestamp":1600427788000},"page":"107684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The role of the brain renin-angiotensin system (RAS) in mild traumatic brain injury (TBI)"],"prefix":"10.1016","volume":"218","author":[{"given":"Jason D.","family":"Vadhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Speth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107684_bb0005","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1007\/s12035-017-0812-z","article-title":"Angiotensin II causes neuronal damage in stretch-injured neurons: Protective effects of losartan, an angiotensin T1 receptor blocker","volume":"55","author":"Abdul-Muneer","year":"2018","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0010","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1023\/A:1021191729865","article-title":"Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat","volume":"24","author":"Agarwal","year":"1999","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12974-018-1262-x","article-title":"RAS modulation prevents progressive cognitive impairment after experimental stroke: A randomized, blinded preclinical trial","volume":"15","author":"Ahmed","year":"2018","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0020","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/jpet.112.197483","article-title":"AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator","volume":"344","author":"Alhusban","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1196\/annals.1296.043","article-title":"Angiotensin II AT1 receptor blockade decreases brain artery inflammation in a stress-prone rat strain","volume":"1018","author":"Ando","year":"2004","journal-title":"Ann N.Y.Acad.Sci."},{"key":"10.1016\/j.pharmthera.2020.107684_bb0030","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1210\/endo.142.9.8366","article-title":"Peripheral administration of an angiotensin II AT1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress","volume":"142","author":"Armando","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.regpep.2004.04.004","article-title":"Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy","volume":"120","author":"Baker","year":"2004","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0014-2999(93)90558-Y","article-title":"Identification and characterisation of angiotensin II receptor subtypes in human brain","volume":"230","author":"Barnes","year":"1993","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229541","article-title":"Association of combination statin and antihypertensive therapy with reduced Alzheimer\u2019s disease and related dementia risk","volume":"15","author":"Barthold","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206705","article-title":"The association of multiple anti-hypertensive medication classes with Alzheimer\u2019s disease incidence across sex, race, and ethnicity","volume":"13","author":"Barthold","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0065","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1242\/jcs.01284","article-title":"\u201cThe stress of dying\u201d: The role of heat shock proteins in the regulation of apoptosis","volume":"117","author":"Beere","year":"2004","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/CS20160009","article-title":"Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions","volume":"131","author":"Begni","year":"2017","journal-title":"Clinical Science (London, England: 1979)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0075","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","article-title":"Angiotensin II AT(1) receptor blockade ameliorates brain inflammation","volume":"36","author":"Benicky","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0080","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-009-9368-4","article-title":"Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery","volume":"29","author":"Benicky","year":"2009","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11906-014-0512-2","article-title":"Neuroprotective mechanisms of the ACE2-angiotensin-(1\u20137)-mas axis in stroke","volume":"17","author":"Bennion","year":"2015","journal-title":"Current Hypertension Reports"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0090","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1042\/CS20171549","article-title":"Neuroprotection via AT2 receptor agonists in ischemic stroke","volume":"132","author":"Bennion","year":"2018","journal-title":"Clinical Science (London, England: 1979)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0095","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.112.006809","article-title":"A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme","volume":"65","author":"Bernstein","year":"2013","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0105","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","article-title":"Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus","volume":"310","author":"Biancardi","year":"2016","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0110","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0889-1591(02)00021-1","article-title":"Stress and the inflammatory response: A review of neurogenic inflammation","volume":"16","author":"Black","year":"2002","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","article-title":"A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: Implications for the role of neuroplasticity in depression","volume":"11","author":"Brunoni","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","article-title":"Astrocyte roles in traumatic brain injury","volume":"275","author":"Burda","year":"2016","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI112768","article-title":"Circulating and tissue angiotensin systems","volume":"79","author":"Campbell","year":"1987","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0130","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1440-1681.1996.tb03073.x","article-title":"Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists","volume":"3","author":"Campbell","year":"1996","journal-title":"Clinical and Experimental Pharmacology & Physiology. Supplement"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0135","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.cdd.4401035","article-title":"A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death","volume":"9","author":"Castro-Obregon","year":"2002","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0140","first-page":"1129","article-title":"Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor \u03b3 in non-small cell lung cancer","volume":"60","author":"Chang","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0145","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1681\/ASN.2009030307","article-title":"Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent","volume":"21","author":"Chen","year":"2010","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuint.2012.05.012","article-title":"Renin inhibitor aliskiren exerts neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons","volume":"61","author":"Chen","year":"2012","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1533317515618799","article-title":"Use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and risk of dementia in heart failure","volume":"31","author":"Chitnis","year":"2016","journal-title":"American Journal of Alzheimer\u2019s Disease and Other Dementias"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2005.11.049","article-title":"Modulation of the oxidative stress and inflammatory response by PPAR-\u03b3 agonists in the hippocampus of rats exposed to cerebral ischemia\/reperfusion","volume":"530","author":"Collino","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0165","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1006\/jmcc.2002.2106","article-title":"Intracellular angiotensin II increases the long isoform of PDGF mRNA in rat hepatoma cells","volume":"34","author":"Cook","year":"2002","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0170","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/hh2401.101270","article-title":"In vitro evidence for an intracellular site of angiotensin action","volume":"89","author":"Cook","year":"2001","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0175","doi-asserted-by":"crossref","first-page":"713","DOI":"10.33594\/000000167","article-title":"Losartan through Hsp70 avoids angiotensin II induced mesenchymal epithelial transition in proximal tubule cells from spontaneously hypertensive rats","volume":"53","author":"Costantino","year":"2019","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101295","article-title":"Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system","volume":"26","author":"Cui","year":"2019","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0185","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.STR.30.11.2391","article-title":"Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats1","volume":"30","author":"Dai","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0190","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2007.05.039","article-title":"The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions","volume":"581","author":"Daugaard","year":"2007","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0195","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrn3053","article-title":"Repertoire of microglial and macrophage responses after spinal cord injury","volume":"12","author":"David","year":"2011","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0200","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias","volume":"26","author":"Davies","year":"2011","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.regpep.2010.10.003","article-title":"Novel aspects of angiotensin II action in the heart. Implications to myocardial ischemia and heart failure","volume":"166","author":"De Mello","year":"2011","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113310","article-title":"Microglia and macrophage metabolism in CNS injury and disease: The role of immunometabolism in neurodegeneration and neurotrauma","volume":"329","author":"Devanney","year":"2020","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0215","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/HYPERTENSIONAHA.111.173534","article-title":"Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion","volume":"58","author":"Dong","year":"2011","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0220","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/jcbfm.2009.63","article-title":"Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury","volume":"29","author":"Donkin","year":"2009","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0225","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0230","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3389\/fimmu.2018.01753","article-title":"The kaleidoscope of microglial phenotypes","volume":"9","author":"Dubbelaar","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0235","doi-asserted-by":"crossref","first-page":"H2289","DOI":"10.1152\/ajpheart.01096.2004","article-title":"AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats","volume":"288","author":"Duke","year":"2005","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0240","article-title":"Role of BDNF in the pathophysiology and treatment of depression: Activity-dependent effects distinguish rapid-acting antidepressants","author":"Duman","year":"2019","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0245","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1074\/jbc.273.15.8890","article-title":"Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells","volume":"273","author":"Eguchi","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0250","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s12035-018-1300-9","article-title":"Telmisartan protects a microglia cell line from lps injury beyond at1 receptor blockade or PPARgamma activation","volume":"56","author":"Elkahloun","year":"2019","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0255","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004647-200404000-00012","article-title":"The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats","volume":"24","author":"Engelhorn","year":"2004","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0260","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1021\/jm100054f","article-title":"Heat shock protein 70 (hsp70) as an emerging drug target","volume":"53","author":"Evans","year":"2010","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0265","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/HJH.0b013e32830dd5ee","article-title":"Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors","volume":"26","author":"Faure","year":"2008","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0270","first-page":"329","article-title":"Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors","volume":"57","author":"Faure","year":"2006","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0361-9230(99)00072-6","article-title":"The glial scar and central nervous system repair","volume":"49","author":"Fawcett","year":"1999","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0280","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjpo.bp.116.004184","article-title":"Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer\u2019s disease","volume":"3","author":"Fazal","year":"2017","journal-title":"BJPsych Open"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0285","series-title":"eLS","first-page":"1","article-title":"Microglia","author":"Fischer","year":"2020"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0290","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","article-title":"Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells","volume":"29","author":"Fleegal-DeMotta","year":"2009","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0295","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0300","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11906-004-0067-8","article-title":"Is the angiotensin II Type 2 receptor cerebroprotective?","volume":"6","author":"Fournier","year":"2004","journal-title":"Current Hypertension Reports"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0305","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1586\/ern.09.89","article-title":"Prevention of dementia by antihypertensive drugs: How AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors","volume":"9","author":"Fournier","year":"2009","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2020.107684_bb0310","first-page":"S27","article-title":"Bradykinin and neuronal injury","volume":"9","author":"Francel","year":"1992","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0315","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1073\/pnas.84.15.5277","article-title":"Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo","volume":"84","author":"Fr\u00e0ter-Schr\u00f6der","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0320","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.1996.03540140074032","article-title":"The 1996 Albert Lasker medical research awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide","volume":"276","author":"Furchgott","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0325","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cellsig.2018.06.007","article-title":"Angiotensin (1\u20137) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor","volume":"50","author":"Gaidarov","year":"2018","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0330","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1152\/ajpendo.2000.278.3.E357","article-title":"The angiotensin II type 2 receptor: An enigma with multiple variations","volume":"278","author":"Gallinat","year":"2000","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"4613","key":"10.1016\/j.pharmthera.2020.107684_bb0335","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.6879184","article-title":"Angiotensin synthesis in the brain and increased turnover in hypertensive rats","volume":"221","author":"Ganten","year":"1983","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0340","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tips.2012.03.008","article-title":"NADPH oxidases: Novel therapeutic targets for neurodegenerative diseases","volume":"33","author":"Gao","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0345","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002881","article-title":"Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia","volume":"3","author":"Gao","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121551","article-title":"Interaction between angiotensin type 1, type 2, and mas receptors to regulate adult neurogenesis in the brain ventricular-subventricular zone","volume":"8","author":"Garcia-Garrote","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0355","doi-asserted-by":"crossref","first-page":"e1771","DOI":"10.1212\/WNL.0000000000005522","article-title":"Mild TBI and risk of Parkinson disease: A chronic effects of neurotrauma consortium study","volume":"90","author":"Gardner","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mcn.2015.03.001","article-title":"Epidemiology of mild traumatic brain injury and neurodegenerative disease","volume":"66","author":"Gardner","year":"2015","journal-title":"Molecular and Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0365","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1742-2094-9-38","article-title":"Involvement of PPAR-\u03b3 in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: Effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson\u2019s disease","volume":"9","author":"Garrido-Gil","year":"2012","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0370","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00429-012-0402-9","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: An intracellular renin-angiotensin system in the nigra","volume":"218","author":"Garrido-Gil","year":"2013","journal-title":"Brain Structure & Function"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0375","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2014.10.017","article-title":"The role of the nitric oxide pathway in brain injury and its treatment \u2014 From bench to bedside","volume":"263","author":"Garry","year":"2015","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0380","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0385","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2017.05.039","article-title":"BNDF heterozygosity is associated with memory deficits and alterations in cortical and hippocampal EEG power","volume":"332","author":"Geist","year":"2017","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0390","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11010-008-9884-4","article-title":"Angiotensin metabolites can stimulate receptors of the Mas-related genes family","volume":"319","author":"Gembardt","year":"2008","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0395","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41419-018-0913-2","article-title":"Specific inhibition of ADAM17\/TACE promotes neurogenesis in the injured motor cortex","volume":"9","author":"Geribaldi-Doldan","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0400","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1753944715599875","article-title":"Angiotensin-(1\u20137): Beyond its central effects on blood pressure","volume":"9","author":"Gironacci","year":"2015","journal-title":"Therapeutic Advances in Cardiovascular Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0405","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/01.ATV.0000205849.22807.6e","article-title":"Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals","volume":"26","author":"Girouard","year":"2006","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0410","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2010.88","article-title":"Brain-derived neurotrophic factor levels in schizophrenia: A systematic review with meta-analysis","volume":"16","author":"Green","year":"2010","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11906-002-0054-x","article-title":"Microvascular angiogenesis and the renin-angiotensin system","volume":"4","author":"Greene","year":"2002","journal-title":"Current Hypertension Reports"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0420","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0425","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/0006-2952(93)90335-T","article-title":"Angiotensin II and non-angiotensin II displaceable binding sites for [ 3 H]losartan in the rat liver","volume":"46","author":"Grove","year":"1993","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0430","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/jir.2010.0073","article-title":"Role of angiotensin II type 1 receptor in angiotensin II-induced cytokine production in macrophages","volume":"31","author":"Guo","year":"2011","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0435","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nurt.2009.10.021","article-title":"Antioxidant therapies for traumatic brain injury","volume":"7","author":"Hall","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0440","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuropharm.2018.08.005","article-title":"Newer pharmacological approaches for antioxidant neuroprotection in traumatic brain injury","volume":"145","author":"Hall","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0445","doi-asserted-by":"crossref","first-page":"14s","DOI":"10.1016\/0002-9343(91)90279-7","article-title":"Reactive oxygen species in living systems: source, biochemistry, and role in human disease","volume":"91","author":"Halliwell","year":"1991","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0450","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0455","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00424-017-1942-x","article-title":"Macrophages in neuroinflammation: role of the renin-angiotensin-system","volume":"469","author":"Hammer","year":"2017","journal-title":"Pfl\u00fcgers Archiv \/ European Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0460","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: Active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0465","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2010.06.044","article-title":"Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury","volume":"481","author":"Harford-Wright","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0470","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0475","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0169-328X(97)00158-7","article-title":"Alterations in BDNF and NT-3 mRNAs in rat hippocampus after experimental brain trauma","volume":"48","author":"Hicks","year":"1997","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0480","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.242075","article-title":"Substance P: Localization in the central nervous system and in some primary sensory neurons","volume":"190","author":"Hokfelt","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0485","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.0954-6820.2000.00773.x","article-title":"Substance P: A pioneer amongst neuropeptides","volume":"249","author":"H\u00f6kfelt","year":"2001","journal-title":"Journal of Internal Medicine"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2020.107684_bb0490","doi-asserted-by":"crossref","first-page":"Ii81","DOI":"10.1007\/BF03035134","article-title":"Hippocampal damage mediated by corticosteroids--A neuropsychiatric research challenge","volume":"251","author":"Hoschl","year":"2001","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0495","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12264-020-00484-9","article-title":"Microglia-derived NLRP3 activation mediates the pressor effect of prorenin in the rostral ventrolateral medulla of stress-induced hypertensive rats","volume":"36","author":"Hu","year":"2020","journal-title":"Neuroscience Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0500","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12974-016-0697-1","article-title":"Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of \u03b15\u03b21 and \u03b1V\u03b23 integrins","volume":"13","author":"Huang","year":"2016","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0505","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/gbb.12235","article-title":"Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear","volume":"14","author":"Hurt","year":"2015","journal-title":"Genes, Brain, and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0510","first-page":"341","article-title":"The impact of traumatic brain injuries: A global perspective","volume":"22","author":"Hyder","year":"2007","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0515","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s12035-014-8830-6","article-title":"Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats","volume":"51","author":"Ishrat","year":"2015","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0520","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-018-1090-z","article-title":"Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice","volume":"15","author":"Iulita","year":"2018","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0525","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0530","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1089\/neu.2019.6376","article-title":"Subcutaneous administration of angiotensin-(1\u20137) improves recovery after traumatic brain injury in mice","volume":"36","author":"Janatpour","year":"2019","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0535","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of traumatic brain injury: Time for a paradigm shift","volume":"95","author":"Jassam","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0540","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s12035-015-9260-9","article-title":"Angiotensin-(1\u20137) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer\u2019s disease","volume":"53","author":"Jiang","year":"2016","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0545","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1161\/STROKEAHA.107.489765","article-title":"NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke","volume":"38","author":"Kahles","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0550","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2744(73)90021-1","article-title":"Purification of lysosomal prolycarboxypeptidase angiotensinase C","volume":"302","author":"Kakimoto","year":"1973","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0555","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1161\/01.CIR.0000015603.84788.47","article-title":"Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway","volume":"105","author":"Kalra","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0560","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.regpep.2007.03.006","article-title":"Enzymatic pathways of the brain renin-angiotensin system: Unsolved problems and continuing challenges","volume":"143","author":"Karamyan","year":"2007","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0565","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/pr.114.010454","article-title":"Angiotensin receptors: Interpreters of pathophysiological angiotensinergic stimuli","volume":"67","author":"Karnik","year":"2015","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0570","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer\u2019s Disease: Progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"Journal of Alzheimer\u2019s disease: JAD"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0575","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2018.04.004","article-title":"Human adult neurogenesis: Evidence and remaining questions","volume":"23","author":"Kempermann","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134642","article-title":"Heat shock protein signaling in brain ischemia and injury","volume":"715","author":"Kim","year":"2020","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0585","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.nbd.2013.06.012","article-title":"The 70 kDa heat shock protein protects against experimental traumatic brain injury","volume":"58","author":"Kim","year":"2013","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0590","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1038\/s41598-017-07394-3","article-title":"TGFbeta signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults","volume":"7","author":"Kim","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0595","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s11682-015-9442-0","article-title":"Cortical thinning in former professional soccer players","volume":"10","author":"Koerte","year":"2016","journal-title":"Brain Imaging and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0600","first-page":"25","article-title":"Angiotensin receptor blocker candesartan binds to and up-regulates molecular chaperone HSP90 in the hippocampal CA1 neurons - a possible mechanism of neuroprotection by angiotensin receptor blocker","volume":"36","author":"Kokubun","year":"2009","journal-title":"Akita J Med"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0605","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/neu.2015.3949","article-title":"Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury","volume":"33","author":"Korley","year":"2016","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0610","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","article-title":"BDNF: A key factor with multipotent impact on brain signaling and synaptic plasticity","volume":"38","author":"Kowianski","year":"2018","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0615","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1087057111413919","article-title":"Prediction of off-target effects on angiotensin-converting enzyme 2","volume":"16","author":"Kulemina","year":"2011","journal-title":"Journal of Biomolecular Screening"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0620","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1089\/neu.2015.4268","article-title":"Microglial\/macrophage polarization dynamics following traumatic brain injury","volume":"33","author":"Kumar","year":"2016","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0625","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/CS20120089","article-title":"The intracrine renin-angiotensin system","volume":"123","author":"Kumar","year":"2012","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0630","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jneuroim.2019.03.012","article-title":"Toll-like receptors in the pathogenesis of neuroinflammation","volume":"332","author":"Kumar","year":"2019","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0635","first-page":"67","article-title":"Brain renin-angiotensin system and dopaminergic cell vulnerability","volume":"8","author":"Labandeira-Garc\u00eda","year":"2014","journal-title":"Frontiers in Neuroanatomy"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0640","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","article-title":"Brain renin-angiotensin system and microglial polarization: Implications for aging and neurodegeneration","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0645","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1172\/JCI41709","article-title":"Angiotensin II sustains brain inflammation in mice via TGF-beta","volume":"120","author":"Lanz","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0650","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine, a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0655","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1096\/fj.04-2960fje","article-title":"Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury","volume":"19","author":"Li","year":"2005","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0660","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0665","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/290635","article-title":"The prorenin and (Pro)renin receptor: New players in the brain renin-angiotensin system?","volume":"2012","author":"Li","year":"2012","journal-title":"International Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0670","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.114.04458","article-title":"Intracerebroventricular Infusion of the (Pro)renin Receptor Antagonist PRO20 Attenuates Deoxycorticosterone Acetate-Salt-Induced Hypertension","volume":"65","author":"Li","year":"2015","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0675","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.3892\/mmr.2015.4432","article-title":"Candesartan ameliorates acute myocardial infarction in rats through inducible nitric oxide synthase, nuclear factorkappaB, monocyte chemoattractant protein1, activator protein1 and restoration of heat shock protein 72","volume":"12","author":"Lin","year":"2015","journal-title":"Molecular Medicine Reports"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2020.107684_bb0680","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.expneurol.2015.08.018","article-title":"Microglia in the TBI brain: The good, the bad, and the dysregulated","volume":"275","author":"Loane","year":"2016","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134462","article-title":"Extracellular heat shock proteins in neurodegenerative diseases: New perspectives","volume":"711","author":"Lyon","year":"2019","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0690","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0306-3623(94)00292-U","article-title":"The mammalian tachykinin receptors","volume":"26","author":"Maggi","year":"1995","journal-title":"General Pharmacology: The Vascular System"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0695","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202722","article-title":"Monocyte depletion attenuates the development of posttraumatic hydrocephalus and preserves white matter integrity after traumatic brain injury","volume":"13","author":"Makinde","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0700","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Frontiers in Bioscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0705","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.jcbfm.9600080","article-title":"Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic\/ischemic brain injury","volume":"25","author":"Matsumori","year":"2005","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0710","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/STROKEAHA.108.531509","article-title":"Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke","volume":"40","author":"McCarthy","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0715","doi-asserted-by":"crossref","first-page":"e95762","DOI":"10.1371\/journal.pone.0095762","article-title":"Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats","volume":"9","author":"McCarthy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0720","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/1440-1681.12099","article-title":"Brain and retinal microglia in health and disease: An unrecognized target of the renin-angiotensin system","volume":"40","author":"McCarthy","year":"2013","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0725","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0959-4388(95)80028-X","article-title":"Stress and cognitive function","volume":"5","author":"McEwen","year":"1995","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0730","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1113\/expphysiol.2009.047936","article-title":"Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion","volume":"94","author":"Mecca","year":"2009","journal-title":"Experimental Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0735","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","article-title":"Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke","volume":"96","author":"Mecca","year":"2011","journal-title":"Experimental Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0740","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1470320309347789","article-title":"The role of the central renin-angiotensin system in Parkinson\u2019s disease","volume":"11","author":"Mertens","year":"2010","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0745","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s11064-016-1944-7","article-title":"Protective effect of aliskiren in experimental ischemic stroke: Up-regulated p-PI3K, p-AKT, Bcl-2 expression, attenuated bax expression","volume":"41","author":"Miao","year":"2016","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0750","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2009.11.008","article-title":"Molecular mechanisms of the antagonistic action between AT1 and AT2 receptors","volume":"391","author":"Miura","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0755","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1460-9568.2007.06014.x","article-title":"Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation","volume":"27","author":"Miyoshi","year":"2008","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0760","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.redox.2018.09.022","article-title":"AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas\/PKA\/CREB\/UCP-2 pathway after subarachnoid hemorrhage in rats","volume":"20","author":"Mo","year":"2019","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0765","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1179\/016164107X204693","article-title":"Neovascularization following traumatic brain injury: possible evidence for both angiogenesis and vasculogenesis","volume":"29","author":"Morgan","year":"2007","journal-title":"Neurological Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0770","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-1-5","article-title":"PPAR\u03b3, neuroinflammation, and disease","volume":"1","author":"Mrak","year":"2004","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0775","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","article-title":"Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease","volume":"15","author":"Nagahara","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0780","doi-asserted-by":"crossref","first-page":"10663","DOI":"10.1073\/pnas.92.23.10663","article-title":"The angiotensin II type 2 (AT(2)) receptor antagonizes the growth effects of the AT(1) receptor: Gain-of-function study using gene transfer","volume":"92","author":"Nakajima","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.pharmthera.2020.107684_bb0785","first-page":"4027","article-title":"Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide","volume":"56","author":"Nakano","year":"1996","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0790","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2012.11.008","article-title":"AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression","volume":"51","author":"Namsolleck","year":"2013","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0795","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jneuroim.2019.04.005","article-title":"The immunological response to traumatic brain injury","volume":"332","author":"Needham","year":"2019","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0800","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI0214276","article-title":"Pivotal role of the renin\/prorenin receptor in angiotensin II production and cellular responses to renin","volume":"109","author":"Nguyen","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0805","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.npep.2003.12.003","article-title":"Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats","volume":"38","author":"Nimmo","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0810","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0006-8993(00)02377-5","article-title":"Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors","volume":"871","author":"Nishimura","year":"2000","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0815","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM199411033311803","article-title":"Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone","volume":"331","author":"Nolan","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0820","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3233\/JAD-131694","article-title":"Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer\u2019s disease","volume":"40","author":"O\u2019Caoimh","year":"2014","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0825","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1532-5415.2004.52178_7.x","article-title":"Angiotensin-converting enzyme inhibitors and incidence of Alzheimer\u2019s disease in Japan","volume":"52","author":"Ohrui","year":"2004","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0830","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0835","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/1567205014666171016101816","article-title":"Pharmacogenetics of angiotensin-converting enzyme inhibitors in patients with Alzheimer\u2019s disease dementia","volume":"15","author":"de Oliveira","year":"2018","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0840","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3389\/fneur.2019.00942","article-title":"Central application of aliskiren, a renin inhibitor, improves outcome after experimental stroke independent of its blood pressure lowering effect","volume":"10","author":"Panahpour","year":"2019","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0845","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1742-2094-9-102","article-title":"Telmisartan directly ameliorates the neuronal inflammatory response to IL-1beta partly through the JNK\/c-Jun and NADPH oxidase pathways","volume":"9","author":"Pang","year":"2012","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0850","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0855","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000122756","article-title":"Angiotensin in the brain","volume":"25","author":"Phillips","year":"1978","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0860","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1167\/iovs.17-22416","article-title":"The role of angiotensin II\/AT1 receptor signaling in regulating retinal microglial activation","volume":"59","author":"Phipps","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0865","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000111562","article-title":"Brain-derived neurotropic factor\/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia","volume":"16","author":"Pillai","year":"2008","journal-title":"Neurosignals"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0870","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1113\/JP274310","article-title":"The angiotensin II receptor type 1b is the primary sensor of intraluminal pressure in cerebral artery smooth muscle cells","volume":"595","author":"Pires","year":"2017","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0875","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-\u03b3 agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0880","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1073\/pnas.0903958106","article-title":"Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity","volume":"106","author":"Platten","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0885","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.coph.2015.10.008","article-title":"The immune system in traumatic brain injury","volume":"26","author":"Plesnila","year":"2016","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0890","doi-asserted-by":"crossref","first-page":"e12513","DOI":"10.1111\/jpi.12513","article-title":"Antiarrhythmic effect linked to melatonin cardiorenal protection involves AT1 reduction and Hsp70-VDR increase","volume":"65","author":"Prado","year":"2018","journal-title":"Journal of Pineal Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0895","first-page":"283","article-title":"Peroxisome proliferator activated receptor-\u03b3 and traumatic brain injury","volume":"3","author":"Qi","year":"2010","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2005.09.012","article-title":"The intracrine hypothesis: an update","volume":"133","author":"Re","year":"2006","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0905","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/ejn.13228","article-title":"Targeted activation of primitive neural stem cells in the mouse brain","volume":"43","author":"Reeve","year":"2016","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0910","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2013.03.025","article-title":"Anti-inflammatory effects of angiotensin-(1\u20137) in ischemic stroke","volume":"71","author":"Regenhardt","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0915","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0920","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","article-title":"Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS","volume":"31","author":"Rodriguez-Pallares","year":"2008","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0925","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1073\/pnas.0337480100","article-title":"The hippocampus mediates glucocorticoid-induced impairment of spatial memory retrieval: Dependence on the basolateral amygdala","volume":"100","author":"Roozendaal","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0930","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00023210-200216030-00001","article-title":"Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?","volume":"16","author":"Rosenstiel","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0935","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: A systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0940","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(90)90457-H","article-title":"Angiotensin II receptor subtypes in the rat brain","volume":"186","author":"Rowe","year":"1990","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0945","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/edrv-13-2-329","article-title":"Brain and pituitary angiotensin","volume":"13","author":"Saavedra","year":"1992","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0950","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120078","article-title":"Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders","volume":"123","author":"Saavedra","year":"2012","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0955","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.phrs.2017.06.017","article-title":"Beneficial effects of angiotensin II receptor blockers in brain disorders","volume":"125","author":"Saavedra","year":"2017","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0960","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.npp.1300921","article-title":"A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding","volume":"31","author":"Saavedra","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0965","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/01.hjh.0000220418.09021.ee","article-title":"Angiotensin II: Multitasking in the brain","volume":"24","author":"Saavedra","year":"2006","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0970","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","article-title":"Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications","volume":"36","author":"Saavedra","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154860","article-title":"Losartan modulates brain inflammation and improves mood disorders and memory impairment induced by innate immune activation: The role of PPAR-gamma activation","volume":"125","author":"Salmani","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0980","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/CIRCRESAHA.117.305853","article-title":"Involvement of bone marrow cells and neuroinflammation in hypertension","volume":"117","author":"Santisteban","year":"2015","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0985","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0990","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2337\/db14-1282","article-title":"Angiotensin II induces interleukin-1\u03b2-mediated islet inflammation and \u03b2-cell dysfunction independently of vasoconstrictive effects","volume":"64","author":"Sauter","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2020.107684_bb0995","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20060247","article-title":"Vascular inflammation in hypertension and diabetes: Molecular mechanisms and therapeutic interventions","volume":"112","author":"Savoia","year":"2007","journal-title":"Clinical Science"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1000","doi-asserted-by":"crossref","first-page":"e15052","DOI":"10.1371\/journal.pone.0015052","article-title":"Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes","volume":"5","author":"Schmerbach","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1005","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00109-016-1406-3","article-title":"Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice","volume":"94","author":"Schwengel","year":"2016","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.tips.2006.03.010","article-title":"TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease","volume":"27","author":"Shah","year":"2006","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjopharm.2009.11.001","article-title":"Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review","volume":"7","author":"Shah","year":"2009","journal-title":"The American Journal of Geriatric Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pbb.2012.03.029","article-title":"Experimental hypertension induced vascular dementia: Pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor","volume":"102","author":"Sharma","year":"2012","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/wvn.12167","article-title":"Systematic review of traumatic brain injury and the impact of antioxidant therapy on clinical outcomes","volume":"13","author":"Shen","year":"2016","journal-title":"Worldviews on Evidence-Based Nursing"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1030","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.4161\/cc.10.9.15444","article-title":"The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis","volume":"10","author":"Shen","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1035","doi-asserted-by":"crossref","first-page":"H2676","DOI":"10.1152\/ajpheart.00538.2002","article-title":"Bradykinin-induced proinflammatory signaling mechanisms","volume":"283","author":"Shigematsu","year":"2002","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/jpet.103.060392","article-title":"The effect of central injection of angiotensin-converting enzyme inhibitor and the angiotensin type 1 receptor antagonist on the induction by lipopolysaccharide of fever and brain interleukin-1beta response in rats","volume":"308","author":"Shimizu","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1045","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/HYPERTENSIONAHA.119.14548","article-title":"Central CYP1B1 (Cytochrome P450 1B1)-estradiol metabolite 2-methoxyestradiol protects from hypertension and neuroinflammation in female mice","volume":"75","author":"Singh","year":"2020","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1050","doi-asserted-by":"crossref","first-page":"62s","DOI":"10.1016\/S0895-7061(00)00274-0","article-title":"The role of the AT2 receptor in hypertension","volume":"13","author":"Siragy","year":"2000","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/jcbfm.2010.110","article-title":"The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke","volume":"31","author":"Smeda","year":"2010","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11906-018-0798-6","article-title":"Angiotensin-(1\u20137) and alamandine on experimental models of hypertension and atherosclerosis","volume":"20","author":"de Souza-Neto","year":"2018","journal-title":"Current Hypertension Reports"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1065","article-title":"Mitochondria-targeted antioxidants as potential therapy for the treatment of traumatic brain injury","volume":"8","author":"Stelmashook","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.STR.0000121642.53822.58","article-title":"Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats","volume":"35","author":"Stenman","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1075","doi-asserted-by":"crossref","first-page":"H1241","DOI":"10.1152\/ajpheart.00818.2011","article-title":"G protein-mediated stretch reception","volume":"302","author":"Storch","year":"2012","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1080","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.3201232","article-title":"Astrocytes synthesize angiotensinogen in brain","volume":"242","author":"Stornetta","year":"1988","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1085","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019101997","article-title":"Microglial subtypes: Diversity within the microglial community","volume":"38","author":"Stratoulias","year":"2019","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1172\/JCI7145","article-title":"A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response","volume":"104","author":"Su","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1095","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00176","article-title":"Targeting microglial activation states as a therapeutic avenue in Parkinson\u2019s disease","volume":"9","author":"Subramaniam","year":"2017","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001756-200503150-00004","article-title":"Candesartan reduces superoxide production after global cerebral ischemia","volume":"16","author":"Sugawara","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fnint.2013.00055","article-title":"Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: Systematic review and meta-regression analysis","volume":"7","author":"Suliman","year":"2013","journal-title":"Frontiers in Integrative Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1110","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1440-1681.12137","article-title":"Protective arms of the renin\u2013angiotensin-system in neurological disease","volume":"40","author":"Sumners","year":"2013","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mcn.2015.02.014","article-title":"Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus","volume":"65","author":"Sun","year":"2015","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.jcbfm.9600246","article-title":"The carboxyl-terminal domain of inducible Hsp70 protects from ischemic injury in vivo and in vitro","volume":"26","author":"Sun","year":"2005","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuroscience.2004.10.021","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands reduce inflammation and infarction size in transient focal ischemia","volume":"130","author":"Sundararajan","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/cvr\/cvr254","article-title":"Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats","volume":"92","author":"Taniguchi","year":"2011","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.physbeh.2009.09.008","article-title":"The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: Implications for hippocampal volume reductions in depression","volume":"99","author":"Tata","year":"2010","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1140","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1089\/neu.2008.0853","article-title":"The novel nitric oxide synthase inhibitor 4-amino-tetrahydro-L-biopterine prevents brain edema formation and intracranial hypertension following traumatic brain injury in mice","volume":"26","author":"Terpolilli","year":"2009","journal-title":"Journal of Neurotrauma"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.116.07572","article-title":"G-protein-coupled receptor MrgD is a receptor for angiotensin-(1\u20137) involving adenylyl cyclase, cAMP, and phosphokinase A","volume":"68","author":"Tetzner","year":"2016","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2018.05.031","article-title":"Decarboxylation of Ang-(1\u20137) to Ala(1)-Ang-(1\u20137) leads to significant changes in pharmacodynamics","volume":"833","author":"Tetzner","year":"2018","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnagi.2019.00063","article-title":"Angiotensin II receptor 1 blockage limits brain damage and improves functional outcome after brain injury in aged animals despite age-dependent reduction in AT1 expression","volume":"11","author":"Timaru-Kast","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/CCM.0b013e31822f08b9","article-title":"Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma","volume":"40","author":"Timaru-Kast","year":"2012","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1165","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.94.1.237","article-title":"Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor","volume":"94","author":"Tontonoz","year":"1997","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1175","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.WCB.0000054756.97390.F7","article-title":"Overexpression of rat heat shock protein 70 is associated with reduction of early mitochondrial cytochrome C release and subsequent DNA fragmentation after permanent focal ischemia","volume":"23","author":"Tsuchiya","year":"2003","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1180","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1139\/y02-021","article-title":"ACEH\/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors","volume":"80","author":"Turner","year":"2002","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1185","series-title":"Brain Edema XIII, Vienna","first-page":"263","author":"Turner","year":"2006"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s13311-014-0286-x","article-title":"Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury","volume":"11","author":"Umschweif","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1195","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/jcbfm.2014.93","article-title":"Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling","volume":"34","author":"Umschweif","year":"2014","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1200","doi-asserted-by":"crossref","first-page":"e2427","DOI":"10.1038\/cddis.2016.327","article-title":"Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1205","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awv172","article-title":"Neurorestoration after traumatic brain injury through angiotensin II receptor blockage","volume":"138","author":"Villapol","year":"2015","journal-title":"Brain: A Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1215","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/npp.2012.152","article-title":"Candesartan, an angiotensin II AT(1)-receptor blocker and PPAR-gamma agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice","volume":"37","author":"Villapol","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1220","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/npp.2012.152","article-title":"Candesartan, an angiotensin II AT1-receptor blocker and PPAR-\u03b3 agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice","volume":"37","author":"Villapol","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1225","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fneur.2017.00304","article-title":"The role of substance P in secondary pathophysiology after traumatic brain injury","volume":"8","author":"Vink","year":"2017","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2014.09.009","article-title":"Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils","volume":"126","author":"Wang","year":"2014","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1235","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1523\/JNEUROSCI.1176-04.2004","article-title":"NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius","volume":"24","author":"Wang","year":"2004","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1240","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1245","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2010.138","article-title":"Tumor necrosis factor \u03b1 primes cerebral endothelial cells for erythropoietin-induced angiogenesis","volume":"31","author":"Wang","year":"2011","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1250","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1080\/02699052.2018.1537513","article-title":"Aminoguanidine reverses cognitive deficits and activation of cAMP\/CREB\/BDNF pathway in mouse hippocampus after traumatic brain injury (TBI)","volume":"32","author":"Wang","year":"2018","journal-title":"Brain Injury"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1255","first-page":"576","article-title":"Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury","volume":"36","author":"Wei","year":"2016","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1260","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/01.STR.22.7.910","article-title":"Captopril improves neurologic outcome from incomplete cerebral ischemia in rats","volume":"22","author":"Werner","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1270","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0196-9781(93)90121-V","article-title":"Binding of [ 3 H]angiotensin II and [ 3 H]DuP 753 (Losartan) to rat liver homogenates reveals multiple sites. Relationship to AT 1A - and AT 1B - type angiotensin receptors and novel nonangiotensin binding sites","volume":"14","author":"Widdowson","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1275","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.biochem.70.1.341","article-title":"Peroxisome proliferator\u2013activated receptor \u03b3 and metabolic disease","volume":"70","author":"Willson","year":"2001","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1280","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbb.2016.06.010","article-title":"Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression","volume":"148","author":"Wincewicz","year":"2016","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00424-012-1102-2","article-title":"The brain renin-angiotensin system: A diversity of functions and implications for CNS diseases","volume":"465","author":"Wright","year":"2013","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1290","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1227\/NEU.0b013e31820c06b9","article-title":"Induction of angiogenesis and modulation of vascular endothelial growth factor receptor-2 by simvastatin after traumatic brain injury","volume":"68","author":"Wu","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2014.12.007","article-title":"Ang-(1\u20137) exerts protective role in blood\u2013brain barrier damage by the balance of TIMP-1\/MMP-9","volume":"748","author":"Wu","year":"2015","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1673-5374.198964","article-title":"Therapeutic potential of brain-derived neurotrophic factor (BDNF) and a small molecular mimics of BDNF for traumatic brain injury","volume":"12","author":"Wurzelmann","year":"2017","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1305","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5405104","article-title":"The polarization states of microglia in TBI: A new paradigm for pharmacological intervention","volume":"2017","author":"Xu","year":"2017","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1310","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbi.2015.07.015","article-title":"Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKK\u03b2-dependent AMPK activation","volume":"50","author":"Xu","year":"2015","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1315","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.WCB.0000047369.05600.03","article-title":"Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition","volume":"23","author":"Yamakawa","year":"2003","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1320","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/2151402a0","article-title":"Second kininase in human blood plasma","volume":"215","author":"Yang","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1325","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jamapediatrics.2016.0338","article-title":"US youth soccer concussion policy: Heading in the right direction","volume":"170","author":"Yang","year":"2016","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1330","first-page":"74","article-title":"Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection","volume":"1053","author":"Yenari","year":"2005","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1335","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2008.09.074","article-title":"PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms","volume":"1244","author":"Yi","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1340","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","article-title":"Post-synaptic BDNF-TrkB Signaling in synapse maturation, plasticity and disease","volume":"70","author":"Yoshii","year":"2010","journal-title":"Developmental Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1345","series-title":"Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging","first-page":"765","author":"Zeng","year":"2012"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.molbrainres.2004.10.007","article-title":"Cloning and expression of MRG receptors in macaque, mouse, and human","volume":"133","author":"Zhang","year":"2005","journal-title":"Brain Research. Molecular Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1355","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1038\/jcbfm.2013.144","article-title":"Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury","volume":"33","author":"Zhao","year":"2013","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1360","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.jcbfm.9600082","article-title":"Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats","volume":"25","author":"Zhou","year":"2005","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107684_bb1365","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nature Cell Biology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582030214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582030214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:12:04Z","timestamp":1759011124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582030214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":273,"alternative-id":["S016372582030214X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107684","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the brain renin-angiotensin system (RAS) in mild traumatic brain injury (TBI)","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107684"}}